GP-Act III Acquisition Corp. 8-K

What Happened
GP-Act III Acquisition Corp. (GPAT) announced on May 11, 2026 that it and its sponsor (GP-Act III Sponsor LLC) entered into non-redemption agreements with one or more shareholders covering an aggregate of 8,074,387 Class A ordinary shares. Under these agreements, the investors agreed not to redeem those shares and to vote in favor of two proposals at an extraordinary meeting: (1) extend the company’s business-combination deadline from May 13, 2026 to November 13, 2026 (the Extension Amendment Proposal) and (2) amend the trust agreement to move the trustee’s liquidation date to November 13, 2026 (the Trust Amendment Proposal). In exchange, Sponsor HoldCo agreed to transfer an aggregate of 403,720 Class A ordinary shares to those investors, subject to conditions including approval of the proposals and the investors not redeeming the covered shares. The company filed a definitive proxy statement on March 30, 2026 for the meeting (record date March 24, 2026).

Key Details

• Non-Redeemed Shares covered: 8,074,387 Class A ordinary shares.
• Sponsor transfer: up to 403,720 Class A ordinary shares to investors, conditioned on approval and non-redemption.
• Extension requested: deadline to complete a business combination and related trust liquidation moved from May 13, 2026 to November 13, 2026.
• Termination triggers for each agreement include failure to approve the proposals, investor redemption or failure to vote in favor, mutual agreement, or liquidation/dissolution of the company.

Why It Matters
These agreements are intended to increase the likelihood that shareholders approve the extension proposals and to keep more cash in the SPAC’s trust account by reducing redemptions. For retail investors, the outcomes affect (1) whether the SPAC gets more time to complete a merger or acquisition, and (2) how much cash remains in the trust if the extension is approved. The sponsor’s contingent share transfer is a material term that may affect post-combination ownership, and the deals terminate if investors redeem or vote against the proposals.